Asia-Pacific infusion therapy devices market is growing at a CAGR of 6.9% during the forecast period. The rising prevalence and incidence of chronic disease in the region are the major factors contributing to the growth of the market. According to WHO, in contrast to other world regions, the proportions of cancer mortality in Asia and Africa (57.3% and 7.3% respectively) are higher than the proportions of incident cases (48.4% and 5.8% respectively) in 2018. Due to such a rise in cancer mortalities, the government is actively working towards developing awareness among people for cancer, which includes conducting awareness campaigns. For instance, since 1987, the Indian Cancer Society has conducted over 5000 Cancer Awareness Programs which have benefited more than 635,000 participants. As a result, it will drive the demand for infusion therapy devices used in chemotherapy for the treatment of cancer patients in the near future.

Visit for Global Infusion Therapy Devices Market Report at: https://www.omrglobal.com/industry-reports/infusion-therapy-devices-market-size

The Asia-Pacific infusion therapy devices market is segmented on the basis of product type, application, and end-user. Based on the product type,the market is classified into infusion pumps and consumables& accessories. Based on the application, the market is segregated into oncology, diabetes, gastroenterology, analgesia, hematology, and others. The end-user segment is classified into hospitals, home care, and ambulatory surgery centers.

The key players of the Asia-Pacific infusion therapy devices market include JMS Co., Ltd., B. Braun Melsungen AG, Becton, Dickinson, and Co., Medtronic PLC, Moog Inc., Novartis AG, and Terumo Corp. These players are playing a significant role in the growth of the market by providing various products and adopting several strategies such as a merger and acquisition, partnerships and collaboration, technological development, and others. 

Research Methodology

The market study of the Asia-Pacific infusion therapy devices market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalogue

The report is intended for a healthcare service provider, medical device companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Asia-Pacific Infusion Therapy Devices Market Research and Analysis by Product Type

2. Asia-Pacific Infusion Therapy Devices Market Research and Analysis by Application

3. Asia-Pacific Infusion Therapy Devices Market Research and Analysis by End-User

The Report Covers:

• Comprehensive research methodology of the Asia-Pacific infusion therapy devices market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Asia-Pacific infusion therapy devices market.
• Insights about market determinants which are stimulating the Asia-Pacific infusion therapy devices market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.